Sarepta Therapeutics Inc (SRPT)
126.29
+2.20
(+1.77%)
USD |
NASDAQ |
Jan 03, 16:00
126.29
0.00 (0.00%)
After-Hours: 05:42
Sarepta Therapeutics Research and Development Expense (Annual): 877.39M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Arrowhead Pharmaceuticals Inc | 505.87M |
| Alnylam Pharmaceuticals Inc | 1.004B |
| Eli Lilly and Co | 9.313B |
| Catalyst Pharmaceuticals Inc | 93.15M |
| Vertex Pharmaceuticals Inc | 3.69B |